- Home
- SYRE vs ATRO Comparison
SYRE vs ATRO Comparison
Compare SYRE & ATRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- ATRO
- Stock Information
- Founded
- SYRE 2013
- ATRO 1968
- Country
- SYRE United States
- ATRO United States
- Employees
- SYRE N/A
- ATRO N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- ATRO Military/Government/Technical
- Sector
- SYRE Health Care
- ATRO Industrials
- Exchange
- SYRE Nasdaq
- ATRO Nasdaq
- Market Cap
- SYRE 841.4M
- ATRO 844.1M
- IPO Year
- SYRE 2016
- ATRO N/A
- Fundamental
- Price
- SYRE $15.72
- ATRO $36.00
- Analyst Decision
- SYRE Buy
- ATRO Strong Buy
- Analyst Count
- SYRE 6
- ATRO 1
- Target Price
- SYRE $55.00
- ATRO $49.00
- AVG Volume (30 Days)
- SYRE 673.0K
- ATRO 777.8K
- Earning Date
- SYRE 08-06-2025
- ATRO 07-31-2025
- Dividend Yield
- SYRE N/A
- ATRO N/A
- EPS Growth
- SYRE N/A
- ATRO N/A
- EPS
- SYRE N/A
- ATRO N/A
- Revenue
- SYRE N/A
- ATRO $816,288,000.00
- Revenue This Year
- SYRE N/A
- ATRO $8.33
- Revenue Next Year
- SYRE N/A
- ATRO $5.89
- P/E Ratio
- SYRE N/A
- ATRO N/A
- Revenue Growth
- SYRE N/A
- ATRO 13.73
- 52 Week Low
- SYRE $10.91
- ATRO $14.13
- 52 Week High
- SYRE $40.26
- ATRO $36.48
- Technical
- Relative Strength Index (RSI)
- SYRE 51.34
- ATRO 68.09
- Support Level
- SYRE $14.97
- ATRO $29.91
- Resistance Level
- SYRE $16.92
- ATRO $32.60
- Average True Range (ATR)
- SYRE 1.12
- ATRO 1.55
- MACD
- SYRE 0.02
- ATRO -0.14
- Stochastic Oscillator
- SYRE 58.05
- ATRO 94.29
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About ATRO Astronics Corporation
Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.